Aurobindo Pharma Ltd. Investor Presentation

Aurobindo Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Aurobindo Pharma Ltd.
06 Sep 2018
1091.60
-0.77%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that a conference call on acquisition of Sandoz's dermatology and oral solids businesses is scheduled on 6th September 2018 at 5:30 PM Please find attached the dial-in details of the call. In this connection, we enclose herewith the presentation that would be used in the aforesaid conference call....
pdf
logo
Aurobindo Pharma Ltd.
09 Aug 2018
1091.60
-0.77%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please refer to our letter dated 7th August, 2018 wherein we have intimated the schedule of Investors/Analysts call on 10th August, 2018. In this connection, we enclose herewith the presentation that would be used in the Investors/Analysts call on the Unaudited Financial Results of the Company for the first quarter ended 30th June, 2018. The presentation is also being uploaded on the website of the Company - http://www.aurobindo.com/investor-relations/investors/investor-presentation...
pdf
logo
Aurobindo Pharma Ltd.
28 May 2018
1091.60
-0.77%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Sub: Investors/Analysts Presentation Please refer to our letter dated May 28, 2018, wherein we have intimated the schedule of Investors/ Analysts call on May 29, 2018. In this connection, we enclose herewith the presentation to the Investors/Analysts on the Audited Financial Results of the Company for the year ended March 31, 2018....
pdf
logo
Aurobindo Pharma Ltd.
07 Feb 2018
1091.60
-0.77%
Investor Presentation
BSE India
Sub: Investors/Analysts Presentation Please refer to our letter dated 3rd February, 2018 wherein we have intimated the schedule of Investors/Analysts call on 8th February, 2018. In this connection, we enclose herewith the presentation that would be used in the Investors/Analysts call on the Unaudited Financial Results of the Company for the...
pdf
logo
Aurobindo Pharma Ltd.
08 Jan 2018
1091.60
-0.77%
Investor Presentation
BSE India
Sub: JP Morgan Healthcare Conference Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that Company is going to participate in the 36th Annual JP Morgan Healthcare Conference in San Francisco, California to be held from 8 January 2018 to 11 January 2018 in USA....
pdf
logo
Aurobindo Pharma Ltd.
16 Nov 2017, 10:08AM
1091.60
-0.77%
Investor Presentation
BSE India
Sub: Presentation to the Investors / Analysts. We would like to inform you that the Company is participating in investors conference on 16 November 2017 in Mumbai. The attached presentation will be used in the conference. The presentation is also being uploaded on the website of the Company - http://www.aurobindo.com/investor-relations/investors/investor-presentation
pdf
logo
Aurobindo Pharma Ltd.
09 Nov 2017
1091.60
-0.77%
Investor Presentation
BSE India
Please refer to our letter dated 4th November, 2017, wherein we have intimated the schedule of Investors/Analysts call on 10th November, 2017. In this connection, we enclose herewith the presentation to the Investors/Analysts on the Unaudited Financial Results of the Company for the second quarter and half year ended 30th September, 2017 The presentation is also being uploaded on the website of the Company - http://www.aurobindo.com/investor-relations/investors/investor-presentation...
pdf
logo
Aurobindo Pharma Ltd.
20 Sep 2017
1091.60
-0.77%
Investor Presentation
BSE India
Sub: Presentation to the Investors / Analysts. We would like to inform you that the Company is attending investor meetings on 21st September 2017 at Delhi. The presentation used in the investors conference held on 18th August 2017 which was shared with your exchange on 17th August 2017 and uploaded in the following link of our website will be used in the aforesaid investor meetings to be held on 21st September 2017....
pdf
logo
Aurobindo Pharma Ltd.
26 Jun 2017
1091.60
-0.77%
Presentation To The Investors / Analysts.
BSE India
We would like to inform you that the Company is participating in an investors meeting on 27 June 2017 in Mumbai. The attached presentation will be used in the conference. The presentation is also being uploaded on the website of the Company http://www.aurobindo.com/investor-relations/investors/investor-presentation
pdf
logo
Aurobindo Pharma Ltd.
14 Jun 2017
1091.60
-0.77%
Presentation To The Investors / Analysts.
BSE India
We would like to inform you that the Company is participating in Goldman Sachs Healthcare conference on 14 June 2017 in USA starting at 10.30 am of US time. The attached presentation will be used in the conference. The presentation is also being uploaded on the website of the Company http://www.aurobindo.com/investor-relations/investors/investor-presentation Please take the information on record.
pdf